← back to search

Xiaobin Yuan

Shanxi Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Internal medicine, Clinical endpoint, Adverse effect, Lung cancer, and Oncology.
h-index
citations
543
works
8
NIH funding
primary concept
email

Recent publications

Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in <scp>DN</scp>
Journal of Diabetes 2025cited by 9position: middledoi
Epidemiological trends of urolithiasis in working-age populations: Findings from the global burden of disease study 1990–2021
PLoS ONE 2025cited by 8position: middledoi
Unraveling the role of gut microbiota on the formation of nephrolithiasis: insights from integrated analysis of GWAS, single-cell transcriptomics, bulk RNA sequencing and network Pharmacology
Urolithiasis 2025cited by 2position: lastdoi
Clinical comparative study of single-use and reusable digital flexible ureteroscopy for the treatment of lower pole stones: a retrospective case-controlled study
BMC Urology 2024cited by 6position: middledoi
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
The Lancet Respiratory Medicine 2023cited by 69position: middledoi
Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention
PLoS ONE 2023cited by 3position: firstdoi
Renal‑rotation techniques in retroperitoneoscopic adrenalectomy for giant pheochromocytomas: a clinical intervention study with historical controls
BMC Urology 2023cited by 2position: middledoi
Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study
Journal of Thoracic Oncology 2022cited by 23position: middledoi
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
European Journal of Cancer 2022cited by 20position: middledoi
The application of full-size three-dimensional individual printed model combined with three-dimensional digital demonstration can facilitate patient’s preoperative comprehension to robotic-assisted laparoscopic partial nephrectomy
Perioperative Medicine 2022cited by 3position: firstdoi
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia 2021cited by 176position: middledoi
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study
Journal of Thoracic Oncology 2021cited by 16position: middledoi
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
EClinicalMedicine 2021cited by 14position: middledoi
Intratumoral heterogeneity and genetic characteristics of prostate cancer
International Journal of Cancer 2020cited by 48position: middledoi
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
The Lancet Respiratory Medicine 2019cited by 136position: middledoi
Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
Blood 2019cited by 89position: middledoi
Store operated calcium channels are associated with diabetic cystopathy in streptozotocin‑induced diabetic rats
Molecular Medicine Reports 2018cited by 5position: middledoi
Retrolaparoscopic adrenalectomy assisted by three-dimensional reconstructed digital model in a patient with situs inversus totalis
World Journal of Surgical Oncology 2018cited by 2position: firstdoi
Preoperative planning and real-time assisted navigation by three-dimensional individual digital model in partial nephrectomy with three-dimensional laparoscopic system
International Journal of Computer Assisted Radiology and Surgery 2015cited by 37position: middledoi
Endoplasmic reticulum stress is involved in apoptosis of detrusor muscle in streptozocin‐induced diabetic rats
Neurourology and Urodynamics 2015cited by 13position: middledoi
Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014
PLoS ONE 2015cited by 9position: middledoi
Highly differentiated squamous cell carcinoma arising from a suprapubic cystostomy tract in a patient with transplanted kidney.
PubMed 2015cited by 6position: middle
Retroperitoneal Laparoendoscopic Single-Site Adrenalectomy for Pheochromocytoma: Our Single Center Experiences
Journal of Endourology 2013cited by 6position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dongwen Wang · Shanxi Medical University8 papers (2013–2020)Xuhui Zhang · Nanjing Forestry University7 papers (2013–2025)Caoyang Hu · Shanxi Medical University4 papers (2015–2023)Qiang Jing · Shandong University of Technology3 papers (2015–2025)Xiaoming Cao · Shanxi Medical University3 papers (2013–2023)Bin Zhang · Towa Pharmaceutical (Japan)2 papers (2015–2018)Tao Bai · Shanxi Medical University2 papers (2013–2015)Weitao Yao · Shanxi Medical University2 papers (2025–2025)Pengliang Shen · Fudan University2 papers (2020–2023)Ruizhi Xue · Shanxi Medical University2 papers (2023–2023)Xian Yang · Hong Kong Baptist University1 papers (2015–2015)Xiangying Jiao · Shanxi Medical University1 papers (2025–2025)Qin Yang · Guangzhou University of Chinese Medicine1 papers (2015–2015)Xiaoming Cao · Shanxi Medical University1 papers (2023–2023)Xiaolei Liu · Massachusetts Institute of Technology1 papers (2022–2022)Yang Mi · Shanxi Medical University1 papers (2015–2015)Xiaoming Cao · North Carolina State University1 papers (2024–2024)Sen Yang · Shanxi Medical University1 papers (2018–2018)Xiaorong Dong · Lanzhou University Second Hospital1 papers (2021–2021)Jin Wang · Henan Medical University1 papers (2025–2025)